[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.161.175.236. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
March 1988

Action of Topically Applied Arachidonic Acid on the Skin of Patients With Psoriasis

Author Affiliations

From Owen Laboratories, Fort Worth, Tex (Dr Hebborn); Department of Dermatology, Warsaw (Poland) Academy of Medicine (Drs Jablonska, Langner, and Wolska); and Departments of Microbiology and Dermatology, State University of New York at Buffalo (Dr Beutner). Dr Hebborn is now with the Centre International de Recherche Dermatologique, Yalbonne, France.

Arch Dermatol. 1988;124(3):387-391. doi:10.1001/archderm.1988.01670030053021
Abstract

• Concentrations of arachidonic acid ranging from 0.1% to 2% were applied under occlusive dressings to psoriatic plaques in 45 patients. Alleviation of the clinical symptoms of psoriasis including complete clearing in some cases was obtained with the use of 0.5% to 2% arachidonic acid applied under occlusion every 24 to 48 hours five to seven times. Histologic examination showed polymorphonuclear leukocytes penetrating into the stratum corneum and formation of microabscesses or widespread accumulations of polymorphonuclear leukocytes in the stratum corneum, with its eventual destruction. The parakeratotic horny layer became detached; this was followed by restoration of the granular layer and an apparently normal stratum corneum. While arachidonic acid metabolites can be proinflammatory and proproliferative, they may also be important in the healing process for psoriasis.

(Arch Dermatol 1988;124:387-391)

×